NPS RADAR May 2010NPS RADAR May 2010

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR May 2010 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Methoxyflurane (Penthrox) for analgesia (doctor’s bag listing) Professional publication - NPS RADAR - Review Methoxyflurane provides rapid-acting short-term analgesia for use in initial management of acute trauma, via an inhaler device. To avoid renal toxicity, do not exceed maximum doses or use in people with renal impairment.
Colchicine for acute gout: updated information about dosing and drug interactions Professional publication - NPS RADAR - Brief item Updated information about dosing and drug interactions with colchicine for acute gout.
Melatonin prolonged-release tablets (Circadin) for primary insomnia in older people Professional publication - NPS RADAR - Review Prolonged-release melatonin may be used short-term for primary insomnia in people aged ≥ 55 years. It improves quality of sleep and morning alertness in about one-third of patients.
Leeds Sleep Evaluation Questionnaire Professional publication - NPS RADAR - Web only item Brief questionnaire for evaluating sleep

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2010-05-14 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.